Volker Lohmann researcher
Lohmann, Volker
VIAF ID: 311442421 (Personal)
Permalink: http://viaf.org/viaf/311442421
Preferred Forms
- 100 1 _ ‡a Lohmann, Volker
- 100 0 _ ‡a Volker Lohmann ‡c researcher
4xx's: Alternate Name Forms (4)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses | |
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. | |
The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation | |
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor | |
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication | |
Differing and isoform-specific roles for the formin DIAPH3 in plasma membrane blebbing and filopodia formation | |
Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection | |
Erratum for Roth et al., "Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses". | |
Experimental models to study the immunobiology of hepatitis C virus | |
Exploring innate immune induction and interference mechanisms of Hepatitis A and C Viruses in human hepatocytes: a comparative analysis | |
Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo | |
Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases | |
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3. | |
HCV replicons: overview and basic protocols | |
The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response | |
Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development | |
Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy | |
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis | |
Hepatitis C virus replicons: dinosaurs still in business? | |
The hepatitis C virus RNA-dependent RNA polymerase membrane insertion sequence is a transmembrane segment | |
Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha | |
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations | |
Identification of hepatoprotective flavonolignans from silymarin | |
In vitro replicative properties of replicons constructed using sequence variants of the hepatitis C virus strain AD78 that caused a single-source outbreak of hepatitis C. | |
In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. | |
Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation | |
Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives | |
An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection | |
Interaction and Mutual Activation of Different Innate Immune Cells Is Necessary to Kill and Clear Hepatitis C Virus-Infected Cells | |
Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs | |
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses | |
The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A | |
Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential | |
Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin | |
Membrane alterations induced by nonstructural proteins of human norovirus. | |
microRNA-122 amplifies hepatitis C virus translation by shaping the structure of the internal ribosomal entry site. | |
Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus | |
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection | |
Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). | |
Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin A. | |
Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening | |
PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases | |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope | |
Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment | |
Relationships between Hepatitis C Virus Replication and CXCL-8 Production In Vitro | |
Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle | |
A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. | |
Restoration of HCV-specific CD8+ T cell function by interferon-free therapy | |
Role of annexin A2 in the production of infectious hepatitis C virus particles | |
SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations | |
Secretion of Hepatitis C virus replication intermediates reduces activation of Toll-like receptor 3 in hepatocytes | |
Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. | |
Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication. | |
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity | |
Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6). | |
Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα. | |
Ultrastructure of the replication sites of positive-strand RNA viruses | |
Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture |